The small compound Icerguastat reduces muscle defects in oculopharyngeal muscular dystrophy through the PERK pathway of the unfolded protein response

Rima Naït-Saïdi, Aymeric Chartier, Emmanuelle Abgueguen, Philippe Guédat, Martine Simonelig

Open source

DOI
10.1098/rsob.230008
Published
2023-04
Container
Open Biology
Publisher
The Royal Society
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1098/rsob.230008,
  title = {The small compound Icerguastat reduces muscle defects in oculopharyngeal muscular dystrophy through the PERK pathway of the unfolded protein response},
  author = {Rima Naït-Saïdi and Aymeric Chartier and Emmanuelle Abgueguen and Philippe Guédat and Martine Simonelig},
  year = {2023},
  journal = {Open Biology},
  doi = {10.1098/rsob.230008},
  url = {https://doi.org/10.1098/rsob.230008}
}

RIS

TY  - JOUR
TI  - The small compound Icerguastat reduces muscle defects in oculopharyngeal muscular dystrophy through the PERK pathway of the unfolded protein response
AU  - Rima Naït-Saïdi
AU  - Aymeric Chartier
AU  - Emmanuelle Abgueguen
AU  - Philippe Guédat
AU  - Martine Simonelig
PY  - 2023
JO  - Open Biology
DO  - 10.1098/rsob.230008
UR  - https://doi.org/10.1098/rsob.230008
ER  - 

APA

Naït-Saïdi, R., Chartier, A., Abgueguen, E., Guédat, P., & Simonelig, M. (2023). The small compound Icerguastat reduces muscle defects in oculopharyngeal muscular dystrophy through the PERK pathway of the unfolded protein response. Open Biology. https://doi.org/10.1098/rsob.230008

Source records